Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Chiral Se@CeO2 superparticles for ameliorating Parkinson's disease
Ximing
Liu
ab,
Hongyu
Zhang
ab,
Changlong
Hao
*ab,
Hua
Kuang
ab,
Chuanlai
Xu
ab and
Liguang
Xu
*ab
aInternational Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi, Jiangsu 214122, People's Republic of China. E-mail: hcl@jiangnan.edu.cn; xlg@jiangnan.edu.cn
bState Key Laboratory of Food Science and Technology, Jiangnan University, Jiangsu, People's Republic of China
First published on 23rd February 2023
Abstract
Correction for ‘Chiral Se@CeO2 superparticles for ameliorating Parkinson's disease’ by Ximing Liu et al., Nanoscale, 2023, https://doi.org/10.1039/d2nr04534f.
The authors regret an error in Fig. 4C and in Liguang Xu's email address in the original article, and in Fig. S25 and S31 of the ESI. Fig. 4C in the original article showed an incorrect confocal image of D-SP under block clathrin. The corrected Fig. 4C is shown below.
 | ||
| Fig. 1 The TPL intensity of NPs from the corresponding TPL images (Fig. S24 to S26). Data are presented as mean ± s. d. (n = 5). (B) Two-photon luminescence (TPL) intensity of the SP with different treatments. Data are presented as mean ± s. d. (n = 5). (C) Confocal images of MN9D cells after incubating under 4 °C or block caveolin, or block clathrin, or block dynamin. White, SP NPs; blue, DAPI for nuclei. Scale bars, 50 μm. | ||
The correct email address for Liguang Xu is as shown herein.
Fig. S25 showed incorrect two-photon luminescence images of MN9D cells incubated with D-SP for 4 h and 10 h, and Fig. S31 showed an incorrect image of the H&E-stained heart with saline treatment.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2023 |